Martine I. Dujardin1, Abdullah Aldosary1, Peter Gibbs1, Martin D. Pickles1, Lindsay W. Turnbull1
1Centre for MR
This study investigates the ability of ADCs acquired at 3T to predict response to chemoradiotherapy in advanced cervical cancer (N=14). No significant difference between average ADC of responders (complete and partial response) and non-responders (stable and progressive disease) was found (p= 0.06). Mean group ADC values increased systematically with response improvement, supporting further study in a large cohort.